Trial Profile
Phase II 'Proof of Concept' Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Trastuzumab
- Indications Advanced breast cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms AVASTEM
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 19 Mar 2013 Planned end date changed from 1 May 2018 to 1 May 2017 as reported by ClinicalTrials.gov.
- 19 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.